Abstract
Infantile hemangiomas are the most common benign vascular tumours in infants. In this study, we aimed to evaluate the effectiveness of propranolol therapy in patients with infantile hemangioma.
Highlights
Infantile hemangiomas (IH) are the most common type of vascular tumours in infancy and childhood.[1,2] Uncomplicated infantile hemangiomas, can be usually observed up to 18 months
Between September 2015 and September 2019, a total of 236 patients applied to our clinic with the diagnosis of Infantile Hemangioma hemangioma
Similar to the relevant literature, the following points were taken into consideration when the patients were included in the treatment: cases with infantile hemangioma posing cosmetic problems, ulcerated, bleeding, large size, respiratory distress and intention to require surgery if left untreated were treated.[3]
Summary
Infantile hemangiomas (IH) are the most common type of vascular tumours in infancy and childhood.[1,2] Uncomplicated infantile hemangiomas, can be usually observed up to 18 months. Infantile hemangiomas (IH) are the most common type of vascular tumours in infancy and childhood.[1,2]. Uncomplicated infantile hemangiomas, can be usually observed up to 18 months. Patients who did not need treatment were followed up without the propranolol treatment. Infantile hemangiomas should be treated in the setting of bleeding, ulceration, functional dysfunction and Copyright by authors.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
